Schisandrin-loaded β-cyclodextrin nanoparticles for atherosclerosis therapy.

Nanoparticle delivery systems have been extensively investigated as novel therapeutic strategies to promote drug-resistant disease. These nanoparticle formulations demonstrated improved bioavailability and enhanced tissue targeting. Also, there is gr…

Preview only. Read the full abstract at the source